| PGDRX | RIDAX | PGDRX / RIDAX | |
| Total Expense Ratio | 1.37 | 1.34 | 102% |
| Annual Report Gross Expense Ratio | 1.37 | 1.34 | 102% |
| Fund Existence | 10 years | 24 years | - |
| Gain YTD | 14.936 | 8.868 | 168% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.44B | 140B | 2% |
| Annual Yield % from dividends | 2.75 | 2.82 | 97% |
| Returns for 1 year | 14.76 | 8.02 | 184% |
| Returns for 3 years | 19.33 | 24.60 | 79% |
| Returns for 5 years | 21.26 | 24.24 | 88% |
| Returns for 10 years | N/A | 45.97 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RAPCX | 11.10 | 0.04 | +0.36% |
| Cohen & Steers Real Assets C | |||
| LAFGX | 17.31 | 0.05 | +0.29% |
| Lord Abbett International Growth F | |||
| TBCUX | 16.42 | 0.02 | +0.12% |
| Tweedy, Browne Intl Val II - Ccy UnH | |||
| SEVIX | 14.75 | N/A | N/A |
| SEI US Managed Volatility I (SIMT) | |||
| JAGLX | 81.02 | -0.20 | -0.25% |
| Janus Henderson Global Life Sciences T | |||